Comparison of efficacy between the da Vinci surgical system and Toumai® robotic surgical systems for robot-assisted radical prostatectomy and robot-assisted partial nephrectomy

IF 2.9 2区医学 Q2 ONCOLOGY

Ejso Pub Date : 2025-09-02 DOI:10.1016/j.ejso.2025.110426

Yiyang Chen , Zhenghong Liu , Bin Zheng , Xiaolong Qi, Qi Zhang, Feng Liu, Zujie Mao, Pu Zhang, Heng Wang, Haichang Li, Yixuan Mou, Xiaowen Qin, Dahong Zhang, Shuai Wang

{"title":"Comparison of efficacy between the da Vinci surgical system and Toumai® robotic surgical systems for robot-assisted radical prostatectomy and robot-assisted partial nephrectomy","authors":"Yiyang Chen , Zhenghong Liu , Bin Zheng , Xiaolong Qi, Qi Zhang, Feng Liu, Zujie Mao, Pu Zhang, Heng Wang, Haichang Li, Yixuan Mou, Xiaowen Qin, Dahong Zhang, Shuai Wang","doi":"10.1016/j.ejso.2025.110426","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The Toumai® surgical robot, a cutting-edge medical assistance robot, was developed and launched in China.</div></div><div><h3>Objective</h3><div>Compare the effectiveness and safety of the da Vinci robotic surgical system and the Toumai® surgical robot in RARP and RAPN surgeries(the Toumai® -RARP versus the DV-RARP, the Toumai®-RAPN versus the DV-RAPN).</div></div><div><h3>Design, setting, and participants</h3><div>One randomized controlled trials were conducted among patients aged 18–77 years suspected of having T1a N0M0 renal cancer, and another randomized controlled trial was conducted among patients aged 55–79 years suspected of having T2 N0M0 prostate cancer.</div></div><div><h3>Reasults</h3><div>The clinical characteristics of the two groups of patients undergoing the same surgical procedure showed no significant differences. All surgeries were successfully completed without the need for conversion from laparoscopic to open surgery. The operative time in the Toumai® group was significantly longer. Additionally, there were no significant differences between the two groups in key indicators such as blood loss, length of hospital stay, complication rates, and functional outcomes.</div></div><div><h3>Conclusions</h3><div>This comparative study on the efficacy and safety between the Toumai® system and the da Vinci system demonstrates that the Toumai® surgical robot and the da Vinci robotic system achieve comparable safety profiles, surgical outcomes, and postoperative expectations when performing RAPN and RARP procedures, with no statistically significant differences observed.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 11","pages":"Article 110426"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0748798325008546","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The Toumai® surgical robot, a cutting-edge medical assistance robot, was developed and launched in China.

Objective

Compare the effectiveness and safety of the da Vinci robotic surgical system and the Toumai® surgical robot in RARP and RAPN surgeries(the Toumai® -RARP versus the DV-RARP, the Toumai®-RAPN versus the DV-RAPN).

Design, setting, and participants

One randomized controlled trials were conducted among patients aged 18–77 years suspected of having T1a N0M0 renal cancer, and another randomized controlled trial was conducted among patients aged 55–79 years suspected of having T2 N0M0 prostate cancer.

Reasults

The clinical characteristics of the two groups of patients undergoing the same surgical procedure showed no significant differences. All surgeries were successfully completed without the need for conversion from laparoscopic to open surgery. The operative time in the Toumai® group was significantly longer. Additionally, there were no significant differences between the two groups in key indicators such as blood loss, length of hospital stay, complication rates, and functional outcomes.

Conclusions

This comparative study on the efficacy and safety between the Toumai® system and the da Vinci system demonstrates that the Toumai® surgical robot and the da Vinci robotic system achieve comparable safety profiles, surgical outcomes, and postoperative expectations when performing RAPN and RARP procedures, with no statistically significant differences observed.

查看原文本刊更多论文

da Vinci手术系统与Toumai®机器人手术系统在机器人辅助前列腺根治术和机器人辅助部分肾切除术中的疗效比较

背景：Toumai®手术机器人是一款尖端的医疗辅助机器人，在中国研发并推出。目的：比较达芬奇机器人手术系统和Toumai®手术机器人在RARP和RAPN手术中的有效性和安全性（Toumai®-RARP与DV-RARP， Toumai®-RAPN与DV-RAPN）。设计、环境及参与者：一项随机对照试验在18-77岁的T1a型N0M0型肾癌疑似患者中进行，另一项随机对照试验在55-79岁的T2型N0M0型前列腺癌疑似患者中进行。结果：两组相同手术方式患者的临床特征无显著差异。所有手术均成功完成，无需从腹腔镜手术转为开放手术。Toumai组的手术时间明显更长。此外，两组在失血量、住院时间、并发症发生率和功能结局等关键指标上没有显著差异。结论：Toumai®系统与达芬奇系统的疗效和安全性比较研究表明，Toumai®手术机器人和达芬奇机器人系统在执行RAPN和RARP手术时具有相当的安全性、手术结果和术后预期，没有统计学上的显著差异。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ejso 医学-外科

CiteScore

6.40

自引率

2.60%

发文量

1148

审稿时长

41 days

期刊介绍： JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.